We are live on ! Find out more
MFIM

Mesirow Financial Investment Management Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+15.29%
1 Year Est. Return
+23.22%
3 Year Est. Return
+69.99%
5 Year Est. Return
+94.22%
10 Year Est. Return
AUM
$23.7M
AUM Growth
-$91K
Cap. Flow
-$2.4M
Cap. Flow %
-10.15%
Top 10 Hldgs %
21.57%
Holding
73
New
14
Increased
1
Reduced
47
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Financials 19.61%
3 Technology 16.42%
4 Industrials 11.9%
5 Consumer Discretionary 11.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
26
DELISTED
Everbridge, Inc. Common Stock
EVBG
$396K 1.67%
5,066
-168
-3% -$13K
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$396K 1.67%
44,644
-1,299
-3% -$10.2K
LMNR icon
28
Limoneira
LMNR
$251M
$392K 1.66%
20,392
-679
-3% -$13K
ALDX icon
29
Aldeyra Therapeutics
ALDX
$91.7M
$388K 1.64%
66,849
-2,180
-3% -$12.6K
CCB icon
30
Coastal Financial
CCB
$754M
$387K 1.63%
23,501
-9,289
-28% -$150K
MYFW icon
31
First Western Financial
MYFW
$308M
$383K 1.62%
29,179
-9,631
-25% -$157K
SKY icon
32
Champion Homes
SKY
$5.1B
$381K 1.61%
12,019
-3,388
-22% -$106K
IMDX
33
Insight Molecular Diagnostics
IMDX
$147M
$365K 1.54%
8,101
-313
-4% -$11.3K
ACEL icon
34
Accel Entertainment
ACEL
$1B
$364K 1.54%
+29,137
New +$317K
INVE icon
35
Identive
INVE
$63.4M
$362K 1.53%
64,202
-2,074
-3% -$10.5K
ALNT icon
36
Allient
ALNT
$1.94B
$360K 1.52%
+11,138
New +$311K
HRTX icon
37
Heron Therapeutics
HRTX
$64.7M
$359K 1.52%
15,295
-7,370
-33% -$163K
ANIP icon
38
ANI Pharmaceuticals
ANIP
$1.73B
$353K 1.49%
5,723
-1,926
-25% -$128K
XRN
39
Chiron Real Estate Inc
XRN
$480M
$350K 1.48%
+5,284
New +$332K
STRL icon
40
Sterling Infrastructure
STRL
$16.8B
$348K 1.47%
24,715
-823
-3% -$12.4K
TVRD
41
Tvardi Therapeutics
TVRD
$22.1M
$341K 1.44%
588
-20
-3% -$14K
DLTH icon
42
Duluth Holdings
DLTH
$151M
$338K 1.43%
32,101
+12,867
+67% +$120K
PINE
43
Alpine Income Property Trust
PINE
$346M
$338K 1.43%
+17,736
New +$334K
ONTO icon
44
Onto Innovation
ONTO
$20.6B
$335K 1.41%
+9,161
New +$311K
TFFP
45
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$334K 1.41%
+2,500
New +$321K
USCR
46
DELISTED
U S Concrete, Inc.
USCR
$331K 1.4%
7,951
-265
-3% -$12.1K
OMER icon
47
Omeros
OMER
$992M
$322K 1.36%
22,838
-762
-3% -$11.2K
OPTN
48
DELISTED
OptiNose
OPTN
$320K 1.35%
+2,317
New +$301K
TISI icon
49
Team
TISI
$101M
$319K 1.35%
1,997
-67
-3% -$11.3K
EXTR icon
50
Extreme Networks
EXTR
$3.2B
$317K 1.34%
42,955
-1,430
-3% -$10K

Similar funds

Mesirow Financial Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Mesirow Financial Investment Management held 73 positions worth $23.7M, down 0.38% from $23.8M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mesirow Financial Investment Management withdrew a net $2.4M in Q4 2019, closing 11 positions and reducing 47 holdings. Its most notable exit was Target Hospitality, an estimated $458K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Mesirow Financial Investment Management opened a new position in Alphatec Holdings worth $463K.

  • Mesirow Financial Investment Management's largest Q4 2019 buy was Alphatec Holdings: 65,244 shares worth $463K.
  • Mesirow Financial Investment Management added most to Duluth Holdings in Q4 2019, an estimated $120K increase.
  • Mesirow Financial Investment Management's biggest Q4 2019 reduction was TriState Capital Holdings, Inc., cutting an estimated $302K.
  • Mesirow Financial Investment Management fully exited Target Hospitality in Q4 2019, selling an estimated $458K.
  • Mesirow Financial Investment Management's ten largest holdings make up 22% of its $23.7M portfolio in Q4 2019.
  • Mesirow Financial Investment Management opened 14 new positions and closed 11 in Q4 2019.
  • Mesirow Financial Investment Management's portfolio value fell 0.38% quarter-over-quarter to $23.7M.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2019, filed 9 Jan 2020.